Browse the full Primary Immunodeficiency Diseases Market (By Disease: Antibody Deficiency, Cellular Immunodeficiency
and Innate Immune Disorder; By Test: Blood Test and Prenatal Testing; By Treatment: Immunoglobulin Replacement Therapy, Antibiotics Therapy, Stem cell and Gene Therapy and Others; By Geography: North America, Europe, Asia Pacific, and Rest of the World) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 report at http://www.
To the Editor: Mycobacterium shigaense is a novel, slow-growing, scotochromogenic mycobacterium (1), initially reported in 2012 as an opportunistic pathogen isolated from skin biopsy samples from a patient with a history of Hodgkin disease and severe cellular immunodeficiency.
a novel slowly growing scotochromogenic mycobacterium that produced nodules in an erythroderma patient with severe cellular immunodeficiency and a history of Hodgkin's disease.
The mechanisms of susceptibility for TB in HD patients are, however, not completely known, but a complex cellular immunodeficiency
has been attributed to HD.
It appears almost exclusively among people with cellular immunodeficiency
, and it can occur with revaccination of people who have become immunosuppressed since their primary vaccination.
Although severe cellular immunodeficiency
can often facilitate the development of many infections, only 4 clinical cases of TB in patients undergoing HCV antiviral therapy have been described in the literature (6-8), and only 1 of these was clearly described as a TB reactivation (7).
Pecher and Funchs suggested that patients with lacaziosis have a cellular immunodeficiency (5).
However, since Jorge Lobo disease is restricted to specific areas of the world and the number of AIDS cases is increasing, especially in Latin America, a possible correlation between HIV infection and Jorge Lobo disease should be considered because of the associated cellular immunodeficiency.